Market Overview:
The global HIV rapid test kit market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of HIV/AIDS, growing awareness about early diagnosis and treatment, and technological advancements in rapid test kits. Based on type, the global HIV rapid test kit market is segmented into blood detection and saliva detection. The blood detection segment is further sub-segmented into lateral flow assay (LFA) and enzyme-linked immunosorbent assay (ELISA). The saliva detection segment is further sub-segmented into oral fluid ELISA (OFE) and oral fluid LFA. Based on application, the global HIV rapid test kit market is divided into donating blood site, hospital, others (including research laboratories and forensic laboratories). Geographically, the global HIV rapid test kit market has been analyzed across North America, Latin America, Europe Asia Pacific & Middle East & Africa.
Product Definition:
A rapid HIV test kit is a diagnostic tool used to detect the presence of HIV antibodies in a person's blood. The test can provide results within minutes, allowing for quick identification of people who may require treatment for HIV infection. The importance of rapid HIV testing is that it allows for timely diagnosis and treatment of the virus, which can improve outcomes for those infected.
Blood Detection:
Blood detection is a process of detecting HIV-1 and -2 in the blood sample by using molecular diagnostic techniques. It aids in early diagnosis and monitoring of HIV infection. The technology has been improved over time with the introduction of new assays, which have faster turnaround times, better accuracy, and are more sensitive than earlier versions.
Saliva Detection:
Saliva detection is a process in which the presence of Salivary gland-specific protein (SGP) in oral fluid is detected and used as an additional test to confirm the HIV infection. The test also helps to differentiate between active tuberculosis and HIV infection.
Application Insights:
Based on application, the global HIV rapid test kit market is segmented into donating blood site, hospital, others. Others include sexual health clinics and home healthcare settings. Hospital was estimated as the largest segment in 2017 owing to presence of a large number of patients suffering from AIDS at hospitals across the world.
The largest share of hospital application is attributed to high usage rate and rising prevalence of HIV among hospitalized patients due to lack of awareness about safe sex practices and availability of infected individuals within hospitals premises for drug sharing which leads to higher risk exposure for acquiring HIV infection. Furthermore, increase in government funding towards prevention programs that target high-risk groups such as MSM will drive demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, availability of advanced products and high adoption rate are some factors contributing to its growth. Moreover, increasing number of blood donations is also expected to boost the demand for rapid HIV tests in this region. For instance, as per a recent article published in CDC's Morbidity and Mortality Weekly Report (MMWR), during 2016 - 2017 period there was an increase of 47% compared with 2015 - 2016 in the number of units donated blood across U.S.
Asia Pacific is anticipated to be the fastest-growing region over the forecast period owing to continuous innovations coupled with rising awareness about HIV testing procedures amongst people living with diagnosed cases as well as those at higher risk such as sex partners or injecting drug users (IDUs). In addition, government initiatives encouraging voluntary testing are also expected drive regional market growth over next eight years.
Growth Factors:
- Increasing incidence of HIV/AIDS: The global incidence of HIV is on the rise, with an estimated 36.7 million people living with the virus in 2017. This is expected to drive demand for rapid HIV tests kits as they offer fast and accurate results.
- Growing awareness about AIDS: There has been a growing awareness about AIDS in recent years, thanks to various campaigns and initiatives by governments and NGOs alike. This is likely to spur demand for rapid HIV tests kits as they can provide results within minutes.
- Rising prevalence of sexually transmitted infections (STIs): The prevalence of STIs is on the rise globally, which is leading more people to seek testing for these infections. This will create opportunities for rapid HIV tests kit manufacturers as these products are faster and easier to use than traditional lab-based tests methods .
Scope Of The Report
Report Attributes
Report Details
Report Title
HIV Rapid Test Kit Market Research Report
By Type
Blood Detection, Saliva Detection
By Application
Donating Blood Site, Hospital, Others
By Companies
AccuBioTech, Abbott, Atomo Diagnostics, Autobio Diagnostics, Chembio Diagnostic Systems, Hologic, LifeSign PBM, Maccura Biotechnology, MedMira, Standard Diagnostics, Orasure Technologies, Wama Diagnostica
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global HIV Rapid Test Kit Market Report Segments:
The global HIV Rapid Test Kit market is segmented on the basis of:
Types
Blood Detection, Saliva Detection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Donating Blood Site, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AccuBioTech
- Abbott
- Atomo Diagnostics
- Autobio Diagnostics
- Chembio Diagnostic Systems
- Hologic
- LifeSign PBM
- Maccura Biotechnology
- MedMira
- Standard Diagnostics
- Orasure Technologies
- Wama Diagnostica
Highlights of The HIV Rapid Test Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood Detection
- Saliva Detection
- By Application:
- Donating Blood Site
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HIV Rapid Test Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The HIV Rapid Test Kit is a home test that can detect the presence of HIV antibodies in blood. It is available as a kit or as an online service.
Some of the key players operating in the hiv rapid test kit market are AccuBioTech, Abbott, Atomo Diagnostics, Autobio Diagnostics, Chembio Diagnostic Systems, Hologic, LifeSign PBM, Maccura Biotechnology, MedMira, Standard Diagnostics, Orasure Technologies, Wama Diagnostica.
The hiv rapid test kit market is expected to grow at a compound annual growth rate of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. HIV Rapid Test Kit Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. HIV Rapid Test Kit Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. HIV Rapid Test Kit Market - Supply Chain
4.5. Global HIV Rapid Test Kit Market Forecast
4.5.1. HIV Rapid Test Kit Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. HIV Rapid Test Kit Market Size (000 Units) and Y-o-Y Growth
4.5.3. HIV Rapid Test Kit Market Absolute $ Opportunity
5. Global HIV Rapid Test Kit Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. HIV Rapid Test Kit Market Size and Volume Forecast by Type
5.3.1. Blood Detection
5.3.2. Saliva Detection
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global HIV Rapid Test Kit Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. HIV Rapid Test Kit Market Size and Volume Forecast by Application
6.3.1. Donating Blood Site
6.3.2. Hospital
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global HIV Rapid Test Kit Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. HIV Rapid Test Kit Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global HIV Rapid Test Kit Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. HIV Rapid Test Kit Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global HIV Rapid Test Kit Demand Share Forecast, 2019-2026
9. North America HIV Rapid Test Kit Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America HIV Rapid Test Kit Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America HIV Rapid Test Kit Market Size and Volume Forecast by Application
9.4.1. Donating Blood Site
9.4.2. Hospital
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America HIV Rapid Test Kit Market Size and Volume Forecast by Type
9.7.1. Blood Detection
9.7.2. Saliva Detection
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America HIV Rapid Test Kit Demand Share Forecast, 2019-2026
10. Latin America HIV Rapid Test Kit Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America HIV Rapid Test Kit Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America HIV Rapid Test Kit Market Size and Volume Forecast by Application
10.4.1. Donating Blood Site
10.4.2. Hospital
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America HIV Rapid Test Kit Market Size and Volume Forecast by Type
10.7.1. Blood Detection
10.7.2. Saliva Detection
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America HIV Rapid Test Kit Demand Share Forecast, 2019-2026
11. Europe HIV Rapid Test Kit Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe HIV Rapid Test Kit Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe HIV Rapid Test Kit Market Size and Volume Forecast by Application
11.4.1. Donating Blood Site
11.4.2. Hospital
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe HIV Rapid Test Kit Market Size and Volume Forecast by Type
11.7.1. Blood Detection
11.7.2. Saliva Detection
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe HIV Rapid Test Kit Demand Share, 2019-2026
12. Asia Pacific HIV Rapid Test Kit Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific HIV Rapid Test Kit Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific HIV Rapid Test Kit Market Size and Volume Forecast by Application
12.4.1. Donating Blood Site
12.4.2. Hospital
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific HIV Rapid Test Kit Market Size and Volume Forecast by Type
12.7.1. Blood Detection
12.7.2. Saliva Detection
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific HIV Rapid Test Kit Demand Share, 2019-2026
13. Middle East & Africa HIV Rapid Test Kit Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa HIV Rapid Test Kit Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa HIV Rapid Test Kit Market Size and Volume Forecast by Application
13.4.1. Donating Blood Site
13.4.2. Hospital
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa HIV Rapid Test Kit Market Size and Volume Forecast by Type
13.7.1. Blood Detection
13.7.2. Saliva Detection
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa HIV Rapid Test Kit Demand Share, 2019-2026
14. Competition Landscape
14.1. Global HIV Rapid Test Kit Market: Market Share Analysis
14.2. HIV Rapid Test Kit Distributors and Customers
14.3. HIV Rapid Test Kit Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AccuBioTech
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Atomo Diagnostics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Autobio Diagnostics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Chembio Diagnostic Systems
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Hologic
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. LifeSign PBM
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Maccura Biotechnology
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. MedMira
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Standard Diagnostics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Orasure Technologies
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Wama Diagnostica
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
